### [2016-04-5](/news/2016/04/5/index.md)

# Pfizer Inc. decides to terminate its $160 billion merger with Allergan, Plc as officials in Washington crack down on corporate inversions. Pfizer will need to pay a $400 million fee to Allergan for expenses relating to the deal. 

Pfizer Inc. decided to terminate its $160 billion merger with Allergan Plc, a person familiar with the matter said, marking an end to the largest-ever health-care acquisition as officials in Washington crack down on corporate inversions.


### Source:

1. [Bloomberg](http://www.bloomberg.com/news/articles/2016-04-06/pfizer-allergan-plan-to-mutually-end-merger-cnbc-reports)

### Related:

1. [The U.S. Treasury Department announces new regulations to curb tax-avoiding corporate inversions, i.e., where U.S. companies slash their tax bills by claiming a new tax home overseas, though their core operations and management remain in the United States. The pending $160 billion merger of Pfizer Inc. and Allergan, Plc could be cancelled because of these new rules. ](/news/2016/04/4/the-u-s-treasury-department-announces-new-regulations-to-curb-tax-avoiding-corporate-inversions-i-e-where-u-s-companies-slash-their-tax.md) _Context: Allergan, Plc, Pfizer Inc., corporate tax inversions_
2. [The Obama Administration through the U.S. Treasury Department will clamp down further on corporate income tax-avoiding inversion deals by U.S. companies with foreign rivals. There is a pending inversion deal between U.S. drug maker Pfizer Inc. and smaller Irish competitor Allergan, Plc. ](/news/2015/11/18/the-obama-administration-through-the-u-s-treasury-department-will-clamp-down-further-on-corporate-income-tax-avoiding-inversion-deals-by-u.md) _Context: Allergan, Plc, Pfizer Inc., corporate tax inversions_
3. [American pharmaceutical companies Pfizer and Allergan, Plc announce plans to merge to form the world's largest drug company. The merger is subject to approval from regulators in the U.S., European Union and elsewhere as well as approval by shareholders of both companies. If approved, the deal will reduce tax revenue paid to the U.S. by approximately $930 million.  ](/news/2015/11/23/american-pharmaceutical-companies-pfizer-and-allergan-plc-announce-plans-to-merge-to-form-the-world-s-largest-drug-company-the-merger-is-s.md) _Context: Allergan, Plc, Pfizer Inc._
4. [The Obama administration's Treasury Department, in a move against corporate tax inversions, enacts regulations to combat a key tax-reduction technique known as earnings stripping. ](/news/2016/10/13/the-obama-administration-s-treasury-department-in-a-move-against-corporate-tax-inversions-enacts-regulations-to-combat-a-key-tax-reduction.md) _Context: corporate tax inversions_
5. [American pharmaceutical company Pfizer announces plans to acquire Hospira at a cost of $17 billion. ](/news/2015/02/5/american-pharmaceutical-company-pfizer-announces-plans-to-acquire-hospira-at-a-cost-of-17-billion.md) _Context: Pfizer Inc._
6. [Fast food giant Burger King agrees to acquire Canadian coffee giant Tim Hortons for $11.4 billion and move its headquarters to Canada. ](/news/2014/08/26/fast-food-giant-burger-king-agrees-to-acquire-canadian-coffee-giant-tim-hortons-for-11-4-billion-and-move-its-headquarters-to-canada.md) _Context: corporate tax inversions_
7. [Pfizer announces plans to release an over-the-counter version of heartburn medication Nexium. ](/news/2014/05/27/pfizer-announces-plans-to-release-an-over-the-counter-version-of-heartburn-medication-nexium.md) _Context: Pfizer Inc._
8. [Drugmaker Pfizer says it will not proceed with its attempted $119 billion bid for AstraZeneca. ](/news/2014/05/26/drugmaker-pfizer-says-it-will-not-proceed-with-its-attempted-119-billion-bid-for-astrazeneca.md) _Context: Pfizer Inc._
9. [AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion.  ](/news/2014/05/19/astrazeneca-rejects-the-latest-and-likely-the-last-takeover-price-from-pfizer-close-to-70-billion-pounds-or-us-118-billion.md) _Context: Pfizer Inc._
10. [Nestl and Danone are said to be bidding for the infant nutrition business that Pfizer is about to put up for sale. ](/news/2012/03/2/nestle-and-danone-are-said-to-be-bidding-for-the-infant-nutrition-business-that-pfizer-is-about-to-put-up-for-sale.md) _Context: Pfizer Inc._
